Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 2
Submit an article Journal homepage
219
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis: Clinical Improvement with Infliximab

Priya SamaliaGreenlane Clinical Centre, Auckland, New ZealandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0189-4707View further author information
, MBChB, PhDORCID Icon,
Joanne SimsGreenlane Clinical Centre, Auckland, New ZealandView further author information
, FRANZCO &
Narme DevaGreenlane Clinical Centre, Auckland, New ZealandView further author information
, FRANZCO
Pages 437-444 | Received 04 Sep 2021, Accepted 29 Nov 2021, Published online: 26 Jan 2022

References

  • Bajgai P, Katoch D, Dogra MR, Singh R. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clin Ophthalmol. Oct 6 2017;11:1805–1817. doi:10.2147/OPTH.S128506.
  • Chang TS, Aylward GW, Davis JL, et al. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Retinal vasculitis study. Ophthalmology. Jul 1995;102(7):1089–1097. doi:10.1016/s0161-6420(95)30907-4.
  • Samuel MA, Equi RA, Chang TS, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology. Aug 2007;114(8):1526–1529.e1. doi:10.1016/j.ophtha.2006.11.014.
  • Saatci AO, Ayhan Z, Takeş O, Yaman A, Bajin FM. Single bilateral dexamethasone implant in addition to panretinal photocoagulation and oral azathioprine treatment in IRVAN syndrome. Case Rep Ophthalmol. Feb 2015;6(1):56–62. doi:10.1159/000375481.
  • Massicotte E, Hassanaly S, Belair ML, Oliver K, Fortin E. Long-term outcomes in a series of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome. Can J Ophthalmol. Oct 2018;53(5):435–440. doi:10.1016/j.jcjo.2017.12.015.
  • Zhang Y, Chang T, Ge G, Zhang M. Extensive dynamics of aneurysms and long-term prognosis in IRVAN syndrome: a case series. Ocul Immunol Inflamm. Sep 2020;29:1–5. doi:10.1080/09273948.2020.1821902.
  • Liu XC, Zhang MN, Chen B, Li Y, Huang HB. A new perspective for analyzing clinical characteristics of idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. Int Ophthalmol. Jul 2019;39(7):1475–1482. doi:10.1007/s10792-018-0962-7.
  • Ramli NM, Zahari M. IRVAN Syndrome. Philipp J Ophthalmol. Jan-Jun 2007;32(1):46–48.
  • Gonzales S, Rampini A, Rubino P, Mora P, Orsoni JG. A case of bilateral idiopathic retinitis, vasculitis, aneurysms and neuroretinitis (IRVAN) treated with discontinuous immunosuppressive therapy. Acta Ophthalmol. Sep 2010;88(s246). doi:10.1111/j.1755-3768.2010.420.x.
  • Cheema RA, Al-Askar E, Cheema HR. Infliximab therapy for idiopathic retinal vasculitis, aneurysm, and neuroretinitis syndrome. J Ocul Pharmacol Ther. Aug 2011;27(4):407–410. doi:10.1089/jop.2010.0189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.